Código QR (código de barras bidimensional)

Advances in second hematopoietic stem cell transplantation

Hematopoietic stem cell transplantation (HSCT) is a widely used treatment for malignant hematological diseases; however, some patients inevitably experience relapse. Therefore, for patients who relapse after the first HSCT (HSCT1), a standard treatment regimen must be developed. A second hematopoiet...

ver descrição completa

Na minha lista:
Principais autores: Sijia Yan, Xiaojian Zhu, Yi Xiao
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2024-07-01
coleção:Frontiers in Immunology
Assuntos:
second hematopoietic stem cell transplantation
relapse
prognostic factor
hematological malignancy
first hematopoietic stem cell transplantation
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1428101/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados